About this Research Topic
Coronaviruses (CoV) are a large family of RNA viruses that cause illness ranging from the common cold to severe diseases. The lethal varieties of CoV can cause coronavirus disease 2019 (COVID-19), Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome (SARS). So Far, there are no vaccines or antiviral drugs to prevent or treat for the infections in humans.
It has been well-recognized that a wide range of bioactive molecules can provide health benefits and possess the therapeutic potential of antivirus, anti-inflammation, immune-regulation, and anti-oxidative stress, and so on.
Theoretically, bioactive molecules may have great potentials for preventing and treating the infections of coronavirus.
The scope of this Research Topic includes Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), coronavirus disease 2019 (COVID-19), and all other coronavirus infections.
It aims to explore the knowledge of the potential efficacy and underlying mechanisms of bioactive molecules against CoV with the assistance of modern tools on the following subtopics but not limited to:
- Molecular biology
- High-throughput biology
- Multi-omics research
- Systems pharmacology
- Genome editing technologies
- Nanotechnology
We invite scientists to contribute both Original Research and Review articles to this Research Topic. The fruitful results might be useful and applied to preventing and treating coronavirus infections in the future.
One can find more information about the Article Types guidelines in the Ethnopharmacology section here).
All the manuscripts submitted to this project will be peer-reviewed and need to fully comply with the Four Pillars of Best Practice in Ethnopharmacology (you can freely download the full version here.
It has been well-recognized that a wide range of bioactive molecules can provide health benefits and possess the therapeutic potential of antivirus, anti-inflammation, immune-regulation, and anti-oxidative stress, and so on.
Theoretically, bioactive molecules may have great potentials for preventing and treating the infections of coronavirus.
The scope of this Research Topic includes Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), coronavirus disease 2019 (COVID-19), and all other coronavirus infections.
It aims to explore the knowledge of the potential efficacy and underlying mechanisms of bioactive molecules against CoV with the assistance of modern tools on the following subtopics but not limited to:
- Molecular biology
- High-throughput biology
- Multi-omics research
- Systems pharmacology
- Genome editing technologies
- Nanotechnology
We invite scientists to contribute both Original Research and Review articles to this Research Topic. The fruitful results might be useful and applied to preventing and treating coronavirus infections in the future.
One can find more information about the Article Types guidelines in the Ethnopharmacology section here).
All the manuscripts submitted to this project will be peer-reviewed and need to fully comply with the Four Pillars of Best Practice in Ethnopharmacology (you can freely download the full version here.
Keywords: bioactive compounds, bioinformatics, coronaviruses, coronavirus disease 2019 (COVID-19), coronavirus pathogenesis, Middle East respiratory syndrome (MERS), molecular biology, multi-omics, natural products, nanotechnology, severe acute respiratory syndrome (SARS), systems pharmacology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
